Metabolism of 17α-Hydroxyprogesterone Caproate, an Agent for Preventing Preterm Birth, by Fetal Hepatocytes

Preterm delivery (i.e., delivery before 37 completed weeks of gestation) is a major determinant of neonatal morbidity and mortality. Until recently, no effective therapies for prevention of preterm birth existed. In a recent multicentered trial, 17α-hydroxyprogesterone caproate (17-OHPC) was shown t...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Sharma, Shringi, Ellis, Ewa C. S., Dorko, Kenneth, Zhang, Shimin, Mattison, Donald R., Caritis, Steve N., Venkataramanan, Raman, Strom, Stephen C.
פורמט: Artigo
שפה:Inglês
יצא לאור: The American Society for Pharmacology and Experimental Therapeutics 2010
נושאים:
Short Communications
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2872946/
https://ncbi.nlm.nih.gov/pubmed/20097724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.109.029918
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים